Literature DB >> 15014624

Mood and Cognitive Changes During Systemic Corticosteroid Therapy.

E Sherwood Brown1, Patricia A. Chandler.   

Abstract

BACKGROUND: Physicians in the United States write approximately 10 million new prescriptions for oral corticosteroids each year. Common side effects of corticosteroids include weight gain, osteoporosis, and diabetes mellitus. This article reviews the available literature on psychiatric and cognitive changes during corticosteroid therapy.
METHOD: A search of the MEDLINE and psycINFO databases was conducted to find clinically relevant articles on psychiatric and cognitive side effects with corticosteroids using search terms including corticosteroid, prednisone, mania, depression, psychosis, mood, memory, and cognition.
RESULTS: Symptoms of hypomania, mania, depression, and psychosis occur during corticosteroid therapy as do cognitive changes, particularly deficits in verbal or declarative memory. Psychiatric symptoms appear to be dose-dependent and generally occur during the first few weeks of therapy. Patients who must remain on corticosteroids may benefit from pharmacotherapeutic approaches, such as lithium and the new antipsychotic medications.
CONCLUSION: Mood and cognitive changes with corticosteroids appear to be common but generally mild and reversible side effects. More studies are needed to determine effective treatment for steroid-induced psychiatric disorders.

Entities:  

Year:  2001        PMID: 15014624      PMCID: PMC181154          DOI: 10.4088/pcc.v03n0104

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


  30 in total

1.  Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment. A prospective study.

Authors:  D Naber; P Sand; B Heigl
Journal:  Psychoneuroendocrinology       Date:  1996-01       Impact factor: 4.905

2.  Lithium prophylaxis of corticotropin-induced psychosis.

Authors:  W E Falk; M W Mahnke; D C Poskanzer
Journal:  JAMA       Date:  1979-03-09       Impact factor: 56.272

Review 3.  Corticosteroids in cancer: neuropsychiatric complications.

Authors:  F C Stiefel; W S Breitbart; J C Holland
Journal:  Cancer Invest       Date:  1989       Impact factor: 2.176

4.  Decreased memory performance in healthy humans induced by stress-level cortisol treatment.

Authors:  J W Newcomer; G Selke; A K Melson; T Hershey; S Craft; K Richards; A L Alderson
Journal:  Arch Gen Psychiatry       Date:  1999-06

Review 5.  Brain corticosteroid receptor balance in health and disease.

Authors:  E R De Kloet; E Vreugdenhil; M S Oitzl; M Joëls
Journal:  Endocr Rev       Date:  1998-06       Impact factor: 19.871

6.  Affective psychoses following renal transplant.

Authors:  D G Blazer; W M Petrie; W P Wilson
Journal:  Dis Nerv Syst       Date:  1976-12

7.  Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews.

Authors:  A M Magariños; B S McEwen; G Flügge; E Fuchs
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

8.  Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature.

Authors:  D A Lewis; R E Smith
Journal:  J Affect Disord       Date:  1983-11       Impact factor: 4.839

9.  Prednisone effects on neurochemistry and behavior. Preliminary findings.

Authors:  O M Wolkowitz; D Rubinow; A R Doran; A Breier; W H Berrettini; M A Kling; D Pickar
Journal:  Arch Gen Psychiatry       Date:  1990-10

Review 10.  Antiepileptic drugs. A review of clinically significant drug interactions.

Authors:  P N Patsalos; J S Duncan
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

View more
  53 in total

1.  Social, professional and neuropsychiatric outcomes in patients with myasthenia gravis.

Authors:  Bruno Kusznir Vitturi; Alexandre In Han Kim; Lucas Pari Mitre; Ada Pellegrinelli; Berenice Cataldo Oliveira Valerio
Journal:  Neurol Sci       Date:  2020-06-26       Impact factor: 3.307

Review 2.  Beyond the joints: neurological involvement in rheumatoid arthritis.

Authors:  Cesar Ramos-Remus; Sergio Duran-Barragan; Jose Dionisio Castillo-Ortiz
Journal:  Clin Rheumatol       Date:  2011-09-20       Impact factor: 2.980

Review 3.  Corticosteroids and Cognition: A Meta-Analysis.

Authors:  Catherine E Prado; Simon F Crowe
Journal:  Neuropsychol Rev       Date:  2019-05-26       Impact factor: 7.444

4.  Acute cognitive and behavioral effects of systemic corticosteroids in children treated for inflammatory bowel disease.

Authors:  Christine Mrakotsky; Peter W Forbes; Jane Holmes Bernstein; Richard J Grand; Athos Bousvaros; Eva Szigethy; Deborah P Waber
Journal:  J Int Neuropsychol Soc       Date:  2012-11-19       Impact factor: 2.892

5.  Psychiatric comorbidities in patients with inflammatory bowel disease.

Authors:  Rasika Bhamre; Sangeet Sawrav; Shilpa Adarkar; Rishika Sakaria; Shobna J Bhatia
Journal:  Indian J Gastroenterol       Date:  2018-09-08

6.  Mental Health in Allergic Rhinitis: Depression and Suicidal Behavior.

Authors:  Ameya U Amritwar; Christopher A Lowry; Lisa A Brenner; Andrew J Hoisington; Robert Hamilton; John W Stiller; Teodor T Postolache
Journal:  Curr Treat Options Allergy       Date:  2017-03-25

Review 7.  Corticosteroids, immune suppression, and psychosis.

Authors:  Dana C Perantie; E Sherwood Brown
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

Review 8.  Clinical Relevance of Steroid Use in Neuro-Oncology.

Authors:  K Ina Ly; Patrick Y Wen
Journal:  Curr Neurol Neurosci Rep       Date:  2017-01       Impact factor: 5.081

9.  Health-related quality of life associated with systemic corticosteroids.

Authors:  Patrick W Sullivan; Vahram H Ghushchyan; Gary Globe; Brandon Sucher
Journal:  Qual Life Res       Date:  2016-10-18       Impact factor: 4.147

10.  Mapping mania symptoms based on focal brain damage.

Authors:  Gonçalo Cotovio; Daniel Talmasov; J Bernardo Barahona-Corrêa; Joey Hsu; Suhan Senova; Ricardo Ribeiro; Louis Soussand; Ana Velosa; Vera Cruz E Silva; Natalia Rost; Ona Wu; Alexander L Cohen; Albino J Oliveira-Maia; Michael D Fox
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.